Roivant Sciences

Argos Therapeutics is funded by a broad syndicate of value-added life science investors, such as TVM, TFG Capital, MDS Capital, Intersouth Partners, Genechem, CDP Capital Technology Ventures, The Aurora Funds and ABN Amro Capital. The company was incorporated in 1997 and operated as Merix Bioscience prior to late 2004. The company s roots are embedded in Duke University, where the company founders developed a unique RNA-based vaccine technology. It specializes in technology related to the generation of dendritic cells and its current therapeutic development and is centered on its broad technology platform. Argos Therapeutics is positioned at the convergence of the scientific, clinical and investor communities and their expanding interest in autologous patient-specific vaccines. Argos Therapeutics is based in Durham, N.C.

KBI Biopharma, located in Durham, NC, is a global Contract Development and Manufacturing Organization (CDMO) that specializes in providing innovative biologic solutions for the development and manufacturing of biopharmaceuticals. With a focus on driving breakthroughs in biopharmaceutical development, KBI Biopharma offers comprehensive services for mammalian and microbial cell line development, process development, analytical development, formulation development, and clinical and commercial manufacturing. By offering cutting-edge, collaborative, and compliant services, KBI Biopharma is redefining the industry with its next-generation CDMO services. The company's expertise in cell line development, process development, analytical development, and manufacturing services for new biologics showcases its commitment to delivering high-quality biopharmaceutical solutions that positively impact the lives of patients worldwide. Generated from the website

ChemoGenics BioPharma, based in Durham, NC, is a leading drug discovery research and service organization offering high-quality and cost-effective solutions for various aspects of the drug discovery process. With a focus on preclinical services, the company has a proven track record of delivering exceptional value to pharmaceutical, biotechnology, academic, and government institutions worldwide. Specializing in medicinal chemistry, cheminformatics, bioinformatics, ADMET, and in vivo pharmacology, ChemoGenics BioPharma boasts a team of scientific experts with over 10 years of experience in the field. Their state-of-the-art facilities and commitment to maximizing clients' intellectual property make them a trusted partner for companies seeking innovative solutions in drug discovery.Generated from the website